Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization - 28/08/11
Doi : 10.1016/S0002-9149(03)00726-4
John H. Chiu, MD a, Eric J. Topol, MD a, Patrick L. Whitlow, MD a, Amy P. Hsu, MS a, E.Murat Tuzcu, MD a, Irving Franco, MD a, David J. Moliterno, MD a, ⁎ 
a Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
*Dr. Moliterno's address is: Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, F-25, Cleveland, Ohio 44195, USA.
Abstract |
The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.
Le texte complet de cet article est disponible en PDF. | TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania. |
© 2003
Excerpta Medica Inc. Tous droits réservés.
Vol 92 - N° 5
P. 582-583 - septembre 2003 Retour au numéro
Article précédent
- Edward David Frohlich, MD: a conversation with the editor
- Effectiveness of stents in small coronary arteries
- Abdulhalim Jamaluddeen Kinsara, Khusrow Niazi, Ishfaq Patel, Osama Amoudi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?